Liquid Biopsy

Sensitivity and coverage for disease monitoring with cfDNA Disease progression and resistance monitoring studies require low cost detection without sacrificing sensitivity. The MassARRAY┬« System can detect variants as low as 0.1% allele frequency at a low cost, making it ideally suited for disease monitoring. While liquid biopsies provide easier access to tumor cells and DNA, … Continue reading Liquid Biopsy